MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CABA had -$80,980K decrease in cash & cash equivalents over the period. -$132,309K in free cash flow.

Cash Flow Overview

Change in Cash
-$80,980K
Free Cash flow
-$132,309K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from the issuance of co...
    • Proceeds from maturities of inve...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of investments
    • Principal payments on finance le...
    • Others

Cash Flow
2025-12-31
Net loss
-167,856
Stock-based compensation
20,939
Depreciation
1,646
Non-cash finance lease expense
11,697
Non-cash operating lease expense
3,671
Accretion of operating lease liabilities
532
Amortization of discount on investments
1,555
Loss on foreign currency exchange rates
225
Prepaid expenses and other current assets
2,559
Other assets
2,866
Accounts payable
1,550
Accrued and other current liabilities
7,432
Lease liabilities
-4,227
Accrued interest payable under finance lease
291
Net cash used in operating activities
-131,080
Purchases of property and equipment
1,229
Purchases of investments
99,037
Proceeds from maturities of investments
50,000
Net cash (used in) provided by investing activities
-50,266
Proceeds from the issuance of common stock, warrants and pre-funded warrants, net of issuance costs
93,558
Issuance of common stock from atm offering, net of sales agent commission and fees
12,745
Proceeds from the issuance of common stock under employee stock purchase plan
291
Proceeds from issuance of common stock in connection with the exercise of stock options
14
Principal payments on finance leases
6,261
Net cash provided by financing activities
100,347
Effect of exchange rate changes on cash and cash equivalents
19
Net decrease in cash and cash equivalents
-80,980
Cash and cash equivalentsbeginning of year
163,962
Cash and cash equivalentsend of year
82,982
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from theissuance of common stock,...$93,558K Issuance of common stockfrom atm offering,...$12,745K Proceeds from theissuance of common stock...$291K Proceeds from issuance ofcommon stock in...$14K Net cash provided byfinancing activities$100,347K Effect of exchange ratechanges on cash and cash...$19K Canceled cashflow$6,261K Net decrease in cashand cash...-$80,980K Canceled cashflow$100,366K Stock-based compensation$20,939K Non-cash finance leaseexpense$11,697K Accrued and othercurrent liabilities$7,432K Non-cash operating leaseexpense$3,671K Depreciation$1,646K Accounts payable$1,550K Accretion of operatinglease liabilities$532K Accrued interestpayable under finance...$291K Loss on foreigncurrency exchange rates$225K Proceeds from maturitiesof investments$50,000K Principal payments onfinance leases$6,261K Net cash used inoperating activities-$131,080K Canceled cashflow$47,983K Net cash (used in)provided by investing...-$50,266K Canceled cashflow$50,000K Net loss-$167,856K Lease liabilities-$4,227K Other assets$2,866K Prepaid expenses andother current assets$2,559K Amortization of discount oninvestments$1,555K Purchases of investments$99,037K Purchases of property andequipment$1,229K

Cabaletta Bio, Inc. (CABA)

Cabaletta Bio, Inc. (CABA)